BioNTech US Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire BioNTech US Inc.
Quantité totale PI 89
Rang # Quantité totale PI 15 377
Note d'activité PI 2,8/5.0    78
Rang # Activité PI 9 100
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

31 2
18 5
29 1
3
 
Dernier brevet 2026 - T cell receptor constructs and u...
Premier brevet 2017 - Neoantigens and methods of their...
Dernière marque 2019 - RECON BIOINFORMATICS ENGINE
Première marque 2016 - RECON

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention T cell receptor compositions and methods of use thereof. The present disclosure provides T cell r...
Invention T cell receptor constructs and uses thereof. The present disclosure provides T cell receptors (T...
Invention T cell manufacturing compositions and methods. Generation of antigen specific T cells by control...
Invention Compositions and methods for t cell manufacturing and uses thereof. ex vivoex vivo stimulated and...
Invention Compositions and methods for t cell manufacturing and uses thereof. Provided herein are methods o...
Invention Ras vaccine compositions and methods of use. The present disclosure provides a therapy with vacci...
Invention Protein antigens and uses thereof. The filed of the present invention relates to immunotherapeut...
Invention Methods for identifying t-cell receptor (tcr) sequences. The present disclosure provides methods ...
Invention T cell receptor constructs and uses thereof. The present disclosure provides T cell receptors (TC...
Invention Methods and compositions for engineering t cells. The present disclosure provides methods for pro...
Invention Vaccine compositions and methods of use. The present disclosure provides a therapy with vaccine c...
Invention Neoantigens and uses thereof. Disclosed herein relates to immunotherapeutic compositions compris...
Invention T cell manufacturing compositions and methods. The generation of antigen specific T cells by con...
2024 Invention Rna vaccines encoding herpes simplex virus glycoproteins and uses thereof. The present disclosure...
Invention Sting agonists containing hydrazide, hydrazine, and hydroxamic acid functional groups. Compounds ...
Invention Sting agonists containing benzylic alcohol and benzylic amine functional groups. Compounds of for...
2023 Invention T cell receptor constructs and uses thereof
Invention T cell manufacturing compositions and methods. ex vivo ex vivo induction or expansion can provide...
Invention T cell manufacturing compositions and methods
Invention Methods and systems for prediction of hla epitopes. Methods for preparing a personalized cancer ...
Invention Methods and systems for prediction of hla epitopes. Methods for preparing a personalized cancer v...
Invention Combination therapy with neoantigen vaccine. The present disclosure relates to neoplasia vaccine...
Invention Combination therapy with neoantigen vaccine. The present disclosure relates to neoplasia vaccine ...
Invention Tissue-specific antigens for cancer immunotherapy. Provided herein are compositions relating to ...
Invention Method and systems for prediction of hla class ii-specific epitopes and characterization of cd4+ ...
Invention Neoantigens and methods of their use. The field of the present invention relates to immunotherap...
Invention Hla-based methods and compositions and uses thereof. Compositions and methods for isolating HLA-...
Invention Pharmaceutical compositions for delivery of herpes simplex virus antigens and related methods. Th...
2022 Invention T cell manufacturing compositions and methods. Generation of antigen specific T cells by controll...
Invention Coronavirus vaccines and methods of use. Compositions and methods for the prevention and/or treat...
2021 Invention Tissue-specific antigens for cancer immunotherapy. Provided herein are compositions relating to t...
Invention T cell manufacturing compositions and methods. The generation of antigen specific T cells by cont...
Invention Ras neoantigens and uses thereof. Compositions and methods for preparing T cell compositions and...
Invention T cell manufacturing compositions and methods. ex vivoex vivo induction or expansion can provide ...
Invention Ras neoantigens and uses thereof. Compositions and methods for preparing T cell compositions and ...
2020 Invention Neoantigen compositions and uses thereof. Disclosed herein relates to immunotherapeutic polypept...
Invention Compositions and methods for preparing t cell compositions and uses thereof. Provided herein are...
Invention Cancer biomarkers for durable clinical benefit. The present disclosure concerns methods of treat...
2019 P/S Pharmaceuticals, namely, immunomodulators; anti-cancer preparations; biological preparations for ...
P/S Pharmaceuticals, namely, immunomodulators; anti-cancer preparations; biological preparations for...
2018 P/S Pharmaceutical preparations for the treatment of cancer, namely, immunotherapies; oncological pre...
P/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes;...
Invention Protein antigens and uses thereof. The field of the present invention relates to immunotherapeuti...
2017 P/S Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; ...
P/S Anti-cancer preparations; biological preparations for the treatment of cancer; pharmaceutical pro...